Partners

Serenus Biotherapeutics has built a team of experienced executives that have an established track record in the Pan African pharmaceuticals market, as well as capabilities in other emerging countries in the Middle East, Latin America, and South East Asia.

We are seeking to broaden our portfolio in Africa and other emerging markets by in-licensing or acquiring rights to commercially attractive products. In-licensing candidates should be approved in at least one of the big pharmaceutical markets, typically the United States, Europe, or Japan.

If you’d like to learn how we can work together to expand the market reach of your drugs, contact Michiel Bröker, Chief Strategy Officer for Serenus.

Contact Us

Email us at info@serenusbio.com or fill out the form below.

Name (required)

Company

Phone

Email (required)

Asset interested in licensing:

Subject:

Message